Distribution of dopamine D1 receptors in rat cortical areas, neostriatum, olfactory bulb and hippocampus in relation to endogenous dopamine contents
- PMID: 2973141
- DOI: 10.1002/syn.890020406
Distribution of dopamine D1 receptors in rat cortical areas, neostriatum, olfactory bulb and hippocampus in relation to endogenous dopamine contents
Abstract
The tritiated dopamine D1 antagonist SCH23390 was employed to determine the densities of D1 receptors in seven discrete and functionally identified cortical areas (cingulate, frontal, parietal, primary somatosensory, primary visual, retrosplenial and entorhinal-piriform) as well as in the neostriatum, hippocampus and olfactory bulbs. In addition, the tissue levels of the catecholamines NA, AD, DA, the indoleamine 5-HT and their main metabolites (MHPG, DOPAC, HVA, 3-MT, 5-HTP and 5-HIAA) were measured in the different regions by HPLC with electrochemical detection. The Scatchard analysis of saturation curves revealed the highest density of [3H]SCH23390 binding sites for the neostriatum, while the densities were 10-20 times lower for total cerebral cortex and hippocampus respectively. For the olfactory bulb and other cortical areas, D1 receptor densities were determined by equilibrium binding at a fixed radioligand concentration approaching saturation. The distribution of D1 receptors was heterogeneous with the greatest densities in entorhinal-piriform and cingulate cortices. The endogenous DA levels measured for all regions correlated with their metabolite (DOPAC, HVA and 3-MT) contents (r = 0.999; P less than 0.001). There was also a very good correlation (r = 0.981; P less than 0.001) between tissue DA and D1 receptor densities. This quantitative information reflects particular features of the organization of the DA systems and is discussed in relation to turnover and recently established aspects of the DA innervation.
Similar articles
-
Distribution of dopamine D1 and D2 receptors in rabbit cortical areas, hippocampus, and neostriatum in relation to dopamine contents.Synapse. 1989;4(4):378-86. doi: 10.1002/syn.890040413. Synapse. 1989. PMID: 2532424
-
Dopamine D(1) and D(2) receptors in the forebrain of dystonia musculorum mutant mice: an autoradiographic survey in relation to dopamine contents.Synapse. 2000 Jul;37(1):1-15. doi: 10.1002/(SICI)1098-2396(200007)37:1<1::AID-SYN1>3.0.CO;2-9. Synapse. 2000. PMID: 10842346
-
Olfactory deprivation increases dopamine D2 receptor density in the rat olfactory bulb.Synapse. 1991 May;8(1):61-70. doi: 10.1002/syn.890080109. Synapse. 1991. PMID: 1831300
-
Specific [3H]SCH23390 binding to dopamine D1 receptors in cerebral cortex and neostriatum: evidence for heterogeneities in affinity states and cortical distribution.J Neurochem. 1988 Feb;50(2):451-63. doi: 10.1111/j.1471-4159.1988.tb02932.x. J Neurochem. 1988. PMID: 2961849
-
[3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.Synapse. 1991 Sep;9(1):14-26. doi: 10.1002/syn.890090104. Synapse. 1991. PMID: 1724575
Cited by
-
Dopamine D1 receptors labelled with [3H]SCH23390 in rabbit cerebral cortex and neostriatum. Equilibrium binding, kinetics and selectivity.Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6):617-25. doi: 10.1007/BF00717736. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2575710
-
Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.Mol Neurobiol. 1992 Winter;6(4):425-50. doi: 10.1007/BF02757945. Mol Neurobiol. 1992. PMID: 1285933
-
Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain.J Neurosci. 2006 Apr 12;26(15):3918-22. doi: 10.1523/JNEUROSCI.4975-05.2006. J Neurosci. 2006. PMID: 16611807 Free PMC article.
-
State-dependent modulation of amygdala inputs by dopamine-induced enhancement of sodium currents in layer V entorhinal cortex.J Neurosci. 2007 Jun 27;27(26):7054-69. doi: 10.1523/JNEUROSCI.1744-07.2007. J Neurosci. 2007. PMID: 17596455 Free PMC article.
-
Brain disposition and catalepsy after intranasal delivery of loxapine: role of metabolism in PK/PD of intranasal CNS drugs.Pharm Res. 2013 Sep;30(9):2368-84. doi: 10.1007/s11095-013-1080-x. Epub 2013 Jun 7. Pharm Res. 2013. PMID: 23739987
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources